{"id":2059,"date":"2021-04-07T20:43:43","date_gmt":"2021-04-07T20:43:43","guid":{"rendered":"https:\/\/vip2-msd.com\/canada\/?page_id=2059"},"modified":"2026-04-06T18:32:59","modified_gmt":"2026-04-06T18:32:59","slug":"newsroom","status":"publish","type":"page","link":"https:\/\/www.merck.ca\/fr\/newsroom\/","title":{"rendered":"Salle de presse"},"content":{"rendered":"\n
\n
\n
\n\n
\n \n\t\n\n\n\n\t\"Online\n<\/picture> <\/div>\n
\n <\/div>\n <\/div>\n\n
\n \n

Salle de presse<\/h1>\n \n

Nos derni\u00e8res nouvelles, annonces et ressources multim\u00e9dias<\/p>\n<\/div>\n \n <\/div>\n <\/div>\n\n \n<\/div>\n\n\n\n

Derni\u00e8res nouvelles<\/strong><\/strong><\/h2>\n\n\n\n
\n
\n

 Le 24 mars 2026<\/p>\n<\/div>\n\n\n\n

\n

Nouvelles inscriptions de produits \u00e0 la liste de m\u00e9dicaments provinciale destin\u00e9es aux Canadiens atteints d\u2019hypertension art\u00e9rielle pulmonaire<\/a><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 18 mars 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada obtient la Certification Parit\u00e9 de niveau or de La Gouvernance au F\u00e9minin <\/strong><\/a><\/strong><\/strong><\/strong><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 13 mars 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Digital Sciences Studio prend de l\u2019ampleur avec une deuxi\u00e8me cohorte visant \u00e0 faire progresser l\u2019industrie biopharmaceutique et la sant\u00e9 num\u00e9rique en Am\u00e9rique du Nord<\/a><\/strong><\/strong><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 17 f\u00e9vrier 2026<\/p>\n<\/div>\n\n\n\n

\n

Sant\u00e9 Canada approuve KEYTRUDA SC\u2122, une pr\u00e9paration sous-cutan\u00e9e du pembrolizumab pour plusieurs indications li\u00e9es au cancer<\/strong><\/a><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 5 f\u00e9vrier 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck annonce l\u2019approbation par Sant\u00e9 Canada d\u2019ENFLONSIA\u00ae pour la pr\u00e9vention de l\u2019infection par le VRS chez les nouveau-n\u00e9s et les nourrissons<\/a><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 8 d\u00e9cembre 2025<\/p>\n<\/div>\n\n\n\n

\n

La Saskatchewan ajoute CAPVAXIVE\u00ae<\/sup> \u00e0 son programme d\u2019immunisation pour les adultes financ\u00e9 par les fonds publics<\/strong><\/strong><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 20 novembre 2025<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada et l\u2019Alliance pancanadienne pharmaceutique (APP) concluent avec succ\u00e8s les n\u00e9gociations relatives \u00e0 WINREVAIR\u00ae<\/sup> (sotatercept)<\/strong><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 5 novembre 2025<\/p>\n<\/div>\n\n\n\n

\n

Le Qu\u00e9bec \u00e9tend le financement public \u00e0 CAPVAXIVE\u00ae<\/sup><\/strong>
<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 13 ao\u00fbt 2025<\/p>\n<\/div>\n\n\n\n

\n

Sant\u00e9 Canada approuve KEYTRUDA\u00ae<\/sup> pour les patients atteints d\u2019un carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 et r\u00e9s\u00e9cable positif pour le PD-L1 (SCP), comme traitement n\u00e9oadjuvant, puis comme traitement adjuvant en association avec une radioth\u00e9rapie avec ou sans cisplatine, puis en monoth\u00e9rapie.<\/strong><\/strong><\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 17 juillet 2025<\/p>\n<\/div>\n\n\n\n

\n

Sant\u00e9 Canada approuve KEYTRUDA\u00ae<\/sup> comme traitement des adultes atteintes d\u2019un cancer du col de l\u2019ut\u00e9rus de stade III \u00e0 IVA selon les crit\u00e8res 2014 de la FIGO, en association avec une chimioradioth\u00e9rapie1<\/sup><\/strong><\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 Le 11 juillet 2025<\/p>\n<\/div>\n\n\n\n

\n

D\u00e9claration de Merck Canada sur les recommandations posologiques relatives \u00e0 GARDASIL\u00ae<\/sup>9<\/strong><\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Le 20 juin 2025<\/p>\n<\/div>\n\n\n\n

\n

Le Merck Digital Sciences Studio ouvre ses portes au Canada pour acc\u00e9l\u00e9rer l\u2019innovation biopharmaceutique<\/strong><\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Le 19 juin 2024<\/p>\n<\/div>\n\n\n\n

\n

MERCK CANADA ENCOURAGE LES CANADIENS \u00c0 METTRE EN PRATIQUE L\u2019APPROCHE INTIME AVEC TA PEAU\u2122<\/sup><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Le 5 mars 2024<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada lance une bourse d’\u00e9tudes pour \u00e9tudiants autochtones<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n

Communiquer avec notre \u00e9quipe des m\u00e9dias<\/strong><\/strong><\/strong><\/h2>\n\n\n\n
Les journalistes qui font une demande de renseignements pour les m\u00e9dias doivent composer le 1 833 90MERCK (1 833 906-3725)<\/a><\/h5>\n\n\n\n

Cette page Web vise \u00e0 fournir aux membres des m\u00e9dias un acc\u00e8s rapide et facile aux renseignements r\u00e9cents sur Merck Canada. Pour de plus amples renseignements sur Merck Canada, veuillez consulter la page No<\/a>tre entreprise<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Derni\u00e8res nouvelles  Le 24 mars 2026 Nouvelles inscriptions de produits \u00e0 la liste de m\u00e9dicaments provinciale destin\u00e9es aux Canadiens atteints d\u2019hypertension art\u00e9rielle pulmonaire  Le 18 mars 2026 Merck Canada obtient la Certification Parit\u00e9 de niveau or de La Gouvernance au F\u00e9minin  Le 13 mars 2026 Merck Digital Sciences Studio prend de l\u2019ampleur avec une deuxi\u00e8me cohorte visant \u00e0 […]<\/p>\n","protected":false},"author":207,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-2059","page","type-page","status-publish","hentry"],"yoast_head":"\nSalle de presse | Merck Canada<\/title>\n<meta name=\"description\" content=\"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merck.ca\/fr\/newsroom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salle de presse | Merck Canada\" \/>\n<meta property=\"og:description\" content=\"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merck.ca\/fr\/newsroom\/\" \/>\n<meta property=\"og:site_name\" content=\"MCC Canada French\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-06T18:32:59+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.merck.ca\/fr\/newsroom\/\",\"url\":\"https:\/\/www.merck.ca\/fr\/newsroom\/\",\"name\":\"Salle de presse | Merck Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.merck.ca\/fr\/#website\"},\"datePublished\":\"2021-04-07T20:43:43+00:00\",\"dateModified\":\"2026-04-06T18:32:59+00:00\",\"description\":\"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.merck.ca\/fr\/newsroom\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.merck.ca\/fr\/#website\",\"url\":\"https:\/\/www.merck.ca\/fr\/\",\"name\":\"MCC Canada French\",\"description\":\"Merck.ca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.merck.ca\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salle de presse | Merck Canada","description":"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merck.ca\/fr\/newsroom\/","og_locale":"en_US","og_type":"article","og_title":"Salle de presse | Merck Canada","og_description":"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.","og_url":"https:\/\/www.merck.ca\/fr\/newsroom\/","og_site_name":"MCC Canada French","article_modified_time":"2026-04-06T18:32:59+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.merck.ca\/fr\/newsroom\/","url":"https:\/\/www.merck.ca\/fr\/newsroom\/","name":"Salle de presse | Merck Canada","isPartOf":{"@id":"https:\/\/www.merck.ca\/fr\/#website"},"datePublished":"2021-04-07T20:43:43+00:00","dateModified":"2026-04-06T18:32:59+00:00","description":"Merck\u00a0Canada dans l\u2019actualit\u00e9 Jetez un coup d\u2019\u0153il aux communiqu\u00e9s de presse et recevez de l\u2019information sur les produits et les d\u00e9clarations de Merck\u00a0Canada.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merck.ca\/fr\/newsroom\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.merck.ca\/fr\/#website","url":"https:\/\/www.merck.ca\/fr\/","name":"MCC Canada French","description":"Merck.ca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merck.ca\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/pages\/2059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/users\/207"}],"replies":[{"embeddable":true,"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/comments?post=2059"}],"version-history":[{"count":191,"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/pages\/2059\/revisions"}],"predecessor-version":[{"id":8609,"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/pages\/2059\/revisions\/8609"}],"wp:attachment":[{"href":"https:\/\/www.merck.ca\/fr\/wp-json\/wp\/v2\/media?parent=2059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}